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Abstract
Background: The chondrosarcoma-derived HCS-2/8 has been known to be an excellent model
of human articular chondrocytes. By mimicking the arthritic conditions through the treatment of
HCS-2/8 cells with cytokines, we estimated the gene expression response of ccn1 and ccn2 during
the course of joint inflammation in vitro.
Results: In order to mimic the initiation of inflammation, HCS-2/8 cells were treated with tumor
necrosis factor (TNF)-α . To induce pro-inflammatory or reparative responses, TGF-β  was
employed. Effects of an anti-inflammatory glucocorticoid were also evaluated. After stimulation,
expression levels of ccn1 and ccn2 were quantitatively analyzed. Surprisingly, not only ccn2, but also
ccn1 expression was repressed upon TNF-α  stimulation, whereas both mRNAs were uniformly
induced by transforming growth factor (TGF)-β  and a glucocorticoid.
Conclusion:  These results describing the same response during the course of inflammation
suggest similar and co-operative roles of these 2 ccn family members in the course of arthritis.
Background
Osteoarthritis (OA) and rheumatoid arthritis (RA) are
most common orthopaedic complexities among aged
individuals [1]. Although they may be etiologically dis-
tinct each other, both are characterized by progressive
destruction of articular cartilage, which is mainly caused
by inflammatory stresses [1]. The most major problem in
the therapeutics of these joint diseases is the difficulty in
regenerating damaged articular cartilage. It is widely rec-
ognized that even a defect of 2 mm in diameter in normal
articular cartilage may not be repaired naturally [2,3].
Therefore, cartilage regeneration is one of the most pre-
ferred subjects for the investigators in medical research
field.
In our previous report, we for the first time clarified that
CCN2/connective tissue growth factor (CTGF) was capa-
ble of regenerating full-thickness defect in articular carti-
lage and promoted the repair of damaged cartilage in an
OA model in vivo [2]. Also, expression of ccn2 in OA cases
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was reported [3]. As such, it is now quite clear that CCN2
is involved in inflammatory response and repair process
of articular cartilage during arthritis. Therefore, it is of crit-
ical importance to investigate the regulation of ccn2
expression along with the course of joint inflammation.
The CCN family is a novel group of proteins that act as
multiple mediators among a variety of extracellular sign-
aling molecules. This family of secreted proteins consists
of 6 members: Cyr61 (CCN1), CTGF (CCN2), Nov
(CCN3), Elm-1/WISP-1 (CCN4), rCop-1/WISP-2/CTGF-L
(CCN5), and WISP-3 (CCN6) [4-9]. These structurally
conserved proteins share 4 modules with sequence simi-
larities to insulin-like growth factor-binding proteins, von
Willebrand factor type C module, thrombospondin type 1
repeat, and growth factor cysteine knots, respectively [4-
9]. CCN2/CTGF is a classical member of CCN family and
shares significantly functional similarities with another
member, CCN1/Cyr61. Both proteins share –45% amino
acid sequence identity [10], bind heparin, are associated
with the ECM [11], and exhibit remarkable functional ver-
satility [12,13]. CCN1 and CCN2 can stimulate chemo-
taxis and promote proliferation of endothelial cells and
fibroblasts in culture, induce neovascularization in vivo,
and promote chondrogenic differentiation, the last-men-
tioned action being consistent with their expression in
prechondrogenic mesenchyme during embryogenesis [5-
7,13-15]. Considering such biological involvement of
CCN1 in mesenchymal tissue formation, active roles of
CCN1 in cartilage regeneration and repair may not be dis-
regarded as well.
Therefore, in our present study, we assessed the gene reg-
ulation profile of CCN1 as well as CCN2 in a human
chondrocytic cell line, HCS-2/8, upon the stimulation
mimicking the course of chronic inflammation. This par-
ticular cell line was selected, since HCS-2/8 was estab-
lished from a chondrosarcoma and has best retained a
variety of mature chondrocytic phenotypes [16-18]. Using
this in vitro model, we found CCN1 may also be involved
in the inflammatory response in joints and may be useful
in cartilage regenerative therapeutics, as described in
CCN2.
Results
Strict and discriminating quantification of ccn1 and ccn2 
mRNAs by real-time-RT-PCR
Since ccn1 and ccn2 are members of the same gene family,
it is critically important to examine the specificity of each
quantification system in order to avoid possible cross-rec-
ognition [4]. First, RT-PCR products of the initial amplifi-
cation under our protocol were separated by 2 % agarose
gel electrophoresis. All of the amplified LightCycler-PCR
products showed single bands of the expected lengths
(i.e., 219 bp for CCN1, 153 bp for CCN2, and 101 bp for
β -actin; Fig. 1B). Second, we further verified the identity of
each PCR product by direct nucleotide sequencing. As a
result, sequence analysis of the PCR products showed 100
% homology to the published sequences. After these ini-
tial examinations, specificity of all of the products was
confirmed each time by melting curve analysis via Light-
Cycler Software 3.39 (Roche). Melting curves were ana-
lyzed for all PCR runs. Continuous fluorescence
monitoring while slowly elevating the temperature
resulted in a sudden decrease in SYBR green I (Roche) flu-
orescence intensity, when denaturation of the PCR prod-
uct occurred. Thus, the melting curve analysis revealed a
specific pattern for each target. Figure 1C shows an exam-
ple of a melting curve analysis, indicating no nonspecific
PCR product. As such, accurate and distinctive quantifica-
tion of ccn1 and ccn2 was deemed warranted.
Repressive response of both ccn1 and ccn2 genes upon 
inflammatory provocation by TNF-α
TNF-α  is one of the best-known inflammatory cytokines
and is involved in a number of inflammatory diseases
including arthritis [1]. Therefore, we evaluated the effect
of TNF-α  on the expression of the ccn1 and ccn2 genes in
the chondrocytic HCS-2/8 cells. HCS-2/8 cells were
treated with 10 nM TNF-α  for 12 – 24 hours. By this stim-
ulation, ccn2 mRNA levels were repressed 0.6 (0.64) to 0.4
(0.41) fold, and ccn1  mRNA levels, 0.9 (0.89) to 0.7
(0.66) fold, by 24 h (Fig. 2A). The result that both genes
were uniformly downregulated upon TNF-α  stimulation
strongly suggests similar or complementary functions of
these gene products in the middle of inflammatory
process.
Induction of ccn1 and ccn2 by pro-inflammatory and 
regenerative signal in chondrocytic HCS-2/8 cells
Tissue repair and regeneration are the last step of inflam-
mation, in which damaged tissue is initially filled with
fibroblasts surrounded by a vast amount of extracellular
matrices (ECM). However, in general, inflammatory stim-
ulation and ECM formation occur in parallel along the
course of chronic inflammation. Through such process,
TGF-β  and CCN2 is known to critically regulate ECM dep-
osition from a variety of mesenchymal cells. Molecular
regulation of ccn2 by TGF-β  has been relatively investi-
gated [19,20]. Nevertheless, little is known concerning the
interplay between ccn1 and TGF-β  in cartilage. As such, we
evaluated the response of ccn1 gene in chondrocytic HCS-
2/8 cells to TGF-β , in comparison with ccn2. Treatment
with 10 ng/ml TGF-β  induced ccn2 mRNA up to 1.5 to 1.9
fold; and ccn1 mRNA, by 1.5 fold up to 24 h (Fig. 2B).
Additionally, we found that these mRNAs were better
induced by 50 ng/ml TGF-β  than by 10 ng/ml (data not
shown). These findings suggest coordinative functions of
ccn1 and ccn2 in repair and chronic inflammation of artic-
ular cartilage.Cell Communication and Signaling 2005, 3:6 http://www.biosignaling.com/content/3/1/6
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Distinctive quantification of ccn1 and ccn2 mRNA by real-time RT-PCR Figure 1
Distinctive quantification of ccn1 and ccn2 mRNA by real-time RT-PCR. A. Primers used for real-time PCR and the 
structures of human ccn1 and ccn2 mRNAs. Schematic representations are illustrated in reference to the modular structure of 
human CCN1 and CCN2 (stippled boxes). The small open circle and AAAAA at the left and right ends denote the 5'-cap 
structure and poly-A tail, respectively. Names, locations for recognition, nucleotide sequence of the primers, and the expected 
sizes of the PCR products are given. Abbreviations: IGFBP, insulin-like growth factor binding module; VWC, von Willebrand 
factor type C module; TSP1, thrombospondin type 1 repeat; CT, C-terminal module. B. The CCN1 (219 bp), CCN2 (153 bp), 
and β -actin (101 bp) PCR products amplified by LightCycler were analyzed by agarose electrophoresis. C. Melting curve analy-
sis of the RT- PCR products of ccn1 and ccn2. Melting curves were acquired after 45 cycles of amplification. Melting curve pat-
tern is displayed on the left panel, where fluorescent intensity (F1) from SYBR green is plotted against temperature. Melting 
peak pattern can be found on the right panel, in which the decrement of F1 is plotted against temperature.Cell Communication and Signaling 2005, 3:6 http://www.biosignaling.com/content/3/1/6
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Coordinative repression and induction of ccn1 and ccn2 transcripts in response to inflammatory TNF-α  (A) and pro-inflamma- tory TGF-β  (B) in chondrocytic HCS-2/8 cells Figure 2
Coordinative repression and induction of ccn1 and ccn2 transcripts in response to inflammatory TNF-α  (A) 
and pro-inflammatory TGF-β  (B) in chondrocytic HCS-2/8 cells. Results of mRNA quantification by real-time RT-PCR 
analysis are displayed. Plotted values represent relative mRNA copy numbers versus those at time 0. Each copy number was 
computed by standardizing the raw data against those of β -actin. Open circles, ccn1; solid circles, ccn2. Mean values and stand-
ard deviations (SDs) of at least 2 experiments are shown.Cell Communication and Signaling 2005, 3:6 http://www.biosignaling.com/content/3/1/6
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Anti-inflammatory treatment and expression of ccn1 and 
ccn2 genes
Glucocorticoids are known to possess strong anti-inflam-
matory effects and also to be involved in the control of
cartilage metabolism [21]. Particularly, the effectiveness
of glucocorticoids on RA symptom is so prominent that it
is frequently applied clinically, despite its adverse sys-
temic effects. It is already known that ccn2 gene expression
is induced by glucocorticoids in chondrocytic cells as well
as in fibroblasts [22,23]. In contrast, molecular interac-
tion between glucocorticoids and ccn1 gene in chondro-
cytes has not been investigated. Thus, we performed
Northern blot analysis, as well as the real-time RT-PCR
quantification to estimate the effects of glucocorticoids on
ccn1 and ccn2 gene expression. When HCS-2/8 cells were
treated with 50 nM dexamethasone for 2.5 – 5 hours and
then examined by real-time PCR, ccn2 mRNA was induced
by 1.8 to 2.3 fold, and ccn1 mRNA was similarly induced
by 1.5 to 1.9 fold up to 5 h (Fig. 3A). The results obtained
by Northern blot analysis were quite similar to the PCR
ones (Fig 3B).
As a control experiment, we carried out similar analysis
with 17β -estradiol, which is another steroid hormone and
is also one of the regulators to maintain the homeostasis
of connective tissue. However, treatment of HCS-2/8 cells
with 10 nM estrogen for 1 – 24 hours resulted in no sig-
nificant change in ccn1 and ccn2 mRNA expression levels.
In fact, no effects were observed even up to the concentra-
tion of 100 nM (data not shown).
Discussion
In this study, we comparatively analyzed the expression
profiles of ccn1 and ccn2, while simulating the course of
arthritis; i.e., inflammation, tissue regeneration and anti-
inflammatory treatment, utilizing a human chondrocytic
HCS-2/8. In advance to the evaluation, we established a
real-time PCR quantification method by using a LightCy-
cler system. In view of the data provided for sensitivity,
linearity, and reproducibility, this assay system accurately
allowed the discriminating quantification of these
mRNAs from the same gene family. The total reliability of
this system was evident, as represented by the facts that
every specific primer set produced distinct and specific
PCR products (Fig. 1) and quantitative results were com-
parable to those of Northern blot analysis (Fig. 3).
The involvement of CCN2 in arthritic diseases has been
indicated. In fact, expression of ccn2 gene in clinical cases
was reported [3]. Also in an experimental OA model, dis-
tinct induction of ccn2  gene expression was observed.
These findings are regarded as a regenerative response of
damaged cartilage, since exogenously applied CCN2 was
proven to be effective in cartilage regeneration. In rat
models, CCN2 captured in collagen hydrogel to allow
gradual release of this factor efficiently promoted the
regeneration of full-thickness cartilage defect and experi-
mentally induced OA cartilage [2]. Therefore, expression
profile of ccn2 in chondrocytes along the time course of
inflammation is thought to represent the proper gene reg-
ulation to provide a regenerative molecule during arthri-
tis, and thus itself is worth investigated. More
interestingly, ccn1 gene expression exactly followed the
fluctuation pattern of ccn2 gene expression upon any kind
of stimulation tested. These results clearly indicate that
not only CCN2, but also CCN1 may be provided as a
regenerative molecule in arthritis. This hypothesis is sup-
ported by a number of their functional similarities.
Indeed, these factors are associated with the ECM, stimu-
late chemotaxis and promote proliferation of endothelial
cells and fibroblasts, and promote neovascularization and
chondrogenic differentiation [7-15,24]. Considering such
similarities and the concomitant fluctuation of gene
expression upon inflammation together, CCN1 is
expected to be one of the useful molecular tools to pro-
mote cartilage regeneration. In order to examine this
hypothesis, it is necessary to evaluate the regenerative
potential of CCN1 protein in damaged articular cartilage,
as was examined with CCN2. In vivo evaluation of the
expression of ccn1 upon OA and RA and the effects of
CCN1 protein on cartilage regeneration is currently in
progress. Since all of the CCN family members are
thought to be mediators of multiple signaling molecules,
therapeutic utility of another member, such as CCN3/
NOV is also expected and obviously, need to be explored.
Conclusion
In vitro simulation of arthritis with a human chondrocytic
cell line revealed the same response pattern of ccn1 as that
of ccn2, which is known as a regenerative mediator in car-
tilage repair. Together with similar functionalities of
CCN1 and CCN2 in mesenchymal tissues, these results
suggest possible utility of CCN1 in regenerative therapy of
damaged mesenchymal tissues.
Methods
Materials
TNF-α  and TGF-β 1 were purchased from Promega (Madi-
son, WI, USA). Dexamethasone and estrogen (17β -estra-
diol) were purchased from Sigma (St. Louis, MO,USA).
Cell culture
HCS-2/8 cells, a chondrocytic cell line derived from a
well-differentiated type of human chondrosarcoma [19],
were maintained in Dulbecco's modified Eagle's medium
(D-MEM) supplemented with 10 % fetal bovine serum
(FBS) under an atmosphere of humidified air containing
5 % CO2. In the experiments in which the effect of estro-
gen was studied, the medium was replaced with phenol
red-free DMEM and 2 mM glutamine (NissuiCell Communication and Signaling 2005, 3:6 http://www.biosignaling.com/content/3/1/6
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Comparable response of ccn1 and ccn2 to anti-inflammatory dexamethasone in HCS-2/8 cells Figure 3
Comparable response of ccn1 and ccn2 to anti-inflammatory dexamethasone in HCS-2/8 cells. A. Expression lev-
els of ccn1 and ccn2 transcripts examined by quantitative real-time PCR. Plotted values represent relative mRNA copy num-
bers, as described in the legend to Figure 2. Open and solid circles denote ccn1 and ccn2, respectively. B. Control experiments 
with estrogen, showing no significant alteration in gene expression either in ccn1, or ccn2. These data are mean values of 2 
experimental results shown with error bars (SD). C. Northern blot analysis of ccn1 and ccn2 gene expression in HCS-2/8 cells 
in response to dexamethasone treatment. The ccn1 and ccn2 mRNAs (upper and middle panels) and total RNAs stained with 
0.02 % methylene blue (lower panel) are shown. : 28S, 28S ribosomal RNA; 18S, 18S ribosomal RNA.Cell Communication and Signaling 2005, 3:6 http://www.biosignaling.com/content/3/1/6
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Pharmaceutical Co. Ltd., Tokyo, Japan) containing 2 %
charcoal-treated FBS, after the HCS-2/8 cells had become
subconfluent. In the experiments with TGF-β 1, dexameth-
asone, and estrogen, the cells were harvested after the
treatment of subconfluent cells (simulating growing
phase upon regeneration) with each factor for the desired
time periods. In the TNF-α  experiment, the cells were har-
vested after the treatment of confluent cells (simulating
quiescent phase before inflammatory damage) with the
factor for the desired time periods.
RNA extraction and reverse transcription (RT)
Total RNA was extracted from HCS-2/8 cells by the acid
guanidinium phenol-chloroform method previously
described [25]. Reverse transcription by avian myelosar-
coma virus reverse transcriptase was carried out by using a
commercially available kit (Takara Shuzo, Tokyo, Japan)
and 1.0 µg of total RNA. Then, the samples were diluted
by 20-fold with RNase-free H2O for subsequent
quantification.
Quantitative real-time PCR amplification
On the basis of the published cDNA sequences of CCN2/
CTGF (GenBank accession no. NM_001901) and CCN1/
Cyr61 (no. AF031385), specific primers were designed for
each. Their nucleotide sequences are displayed in Fig. 1.
Real-time quantitative PCR was performed with a Light-
Cycler system (Roche Molecular Biochemicals, Man-
nheim, Germany). For each assay, reaction mixtures
containing 2.0 µl of a cDNA pool, 1.0 µl of LC DNA Mas-
ter SYBR Green I mixture (Roche), 50 ng of the primers,
and 0.8 µl of 25 mM MgCl2 were prepared on ice. After the
reaction mixtures had been loaded into glass capillary
tubes, amplification was performed under the following
cycling conditions: initial denaturation at 95°C for 10
min, followed by 45 cycles of denaturation at 95°C for 15
sec, annealing at 55°C for 10 sec, and extension at 72°C
for 10 sec. The temperature transition rate was set at
20°C/ sec. The fluorescence representing double-strand
DNA formation was measured in single-acquisition mode
at 72°C after each cycle. For each sample, the cDNA copy
numbers of the target and an internal control (β -actin)
genes were determined based on calibration curves (see
below). The relative amount of the target cDNA was then
computed by dividing the copy number by that of the
internal control to obtain a normalized value. Separate
calibration curves for ccn1, ccn2, and β -actin were prepared
with serially diluted plasmid DNAs containing the target
sequences, which were amplified and evaluated simulta-
neously in each assay. To distinguish specific signal from
non-specific products, melting curve analysis was per-
formed after each amplification cycle. Samples were
maintained at 63°C for 10 sec, and then the temperature
was gradually increased to 95°C at a rate of 0.1°C/sec,
while the signals were monitored with a step-acquisition
mode, as described previously [26]. The real-time PCR
analysis condition was optimised to a level without non-
specific amplification under an acceptable PCR efficiency
(a slope ranging from -2.9 to -4.5). To verify the melting
curve results, we analyzed representative PCR samples in
2.0 % agarose gels, purified and directly sequenced them
from both directions by an automated DNA sequencer
(ABI prism 310 Genetic Analyzer; Applied Biosystems,
Foster City, CA, USA).
Northern blot analysis
Ten micrograms of total RNA was electrophoresed in for-
maldehyde agarose gel and subsequently blotted onto a
nylon membrane. For hybridization probes, CCN2/CTGF
and CCN1/Cyr61 cDNA fragments were prepared by RT-
PCR with pairs of specific primers. Primers specific for
CCN2/CTGF [27] and CCN1/Cyr61 [28] were described
previously. These PCR products were radiolabeled and
used for hybridization as described earlier [20].
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